Abstract 4146166: Effect of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, on Systolic Blood Pressure in Patients with Type 2 Diabetes
Year: 2024
Type: conference-abstract
Source: Circulation
Authors: Marquette Hardin, Michael Davies, Amy Carroll, Guillermo Umpierrez
Institutions: Lexicon Pharmaceuticals (United States), Emory University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404384404
